Scynexis (SCYX) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Scynexis (SCYX) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.75 Bn | 30.81 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -14.91% |
| 10 | Scynexis | 23.82 Mn | -12.93 Mn | - | -3,205.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,205.17% |
| Dec 31, 2025 | -17.95% |
| Sep 30, 2025 | -3,369.51% |
| Mar 31, 2025 | 9.44% |
| Dec 31, 2024 | -306.45% |
| Sep 30, 2024 | -1.72% |
| Jun 30, 2024 | -138.98% |
| Mar 31, 2024 | -251.38% |
| Dec 31, 2023 | -209.91% |
| Sep 30, 2023 | -201.29% |
| Jun 30, 2023 | 628.27% |
| Mar 31, 2023 | 64.13% |
| Dec 31, 2022 | 139.55% |
| Sep 30, 2022 | 17.14% |
| Jun 30, 2022 | 55.12% |
| Mar 31, 2022 | -373.22% |
| Dec 31, 2021 | 77.21% |
| Sep 30, 2021 | 81.11% |
| Jun 30, 2021 | -100.28% |
| Mar 31, 2021 | 87.23% |